Publications by authors named "Olle Stal"

Claim this Profile
P
Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial.
Oscar Danielsson, Huma Dar, Gizeh Perez-Tenorio, Anna Nordenskjöld, Christina Yau

Int J Cancer· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Early-Stage Breast Cancer with a Minimal Risk of Recurrence by the Breast Cancer Index.
Marie-France Jilderda, Yi Zhang, Valerie Rebattu, Ranelle Salunga, Wilma Mesker

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial.
Annelie Johansson, Huma Dar, Anna Nordenskjöld, Gizeh Perez-Tenorio, Nicholas P Tobin

J Natl Cancer Inst· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer.
Josefine Sandström, Jens Bomanson, Gizeh Pérez-Tenorio, Carolin Jönsson, Bo Nordenskjöld

NPJ Breast Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up.
Helena Fohlin, Anna Nordenskjöld, Johan Rosell, Mårten Fernö, Tommy Fornander

Acta Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit.
Terese Engström, Maria Ekholm, Mårten Fernö, Christine Lundgren, Bo Nordenskjöld

Acta Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy.
Anna Nordenskjöld, Helena Fohlin, Johan Rosell, Nils-Olof Bengtsson, Tommy Fornander

Breast· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial.
Christine Lundgren, Julia Tutzauer, Sarah E Church, Olle Stål, Maria Ekholm

Breast Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.
Annelie Johansson, Huma Dar, Laura J van 't Veer, Nicholas P Tobin, Gizeh Perez-Tenorio

J Clin Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study.
Sander Ellegård, Kristina Engvall, Mustafa Asowed, Anna-Lotta Hallbeck, Nils Elander

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature.
Annelie Johansson, Nancy Y Yu, Adina Iftimi, Nicholas P Tobin, Laura van 't Veer

Int J Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients.
Christine Lundgren, Pär-Ola Bendahl, Sarah E Church, Maria Ekholm, Mårten Fernö

NPJ Breast Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
Huma Dar, Annelie Johansson, Anna Nordenskjöld, Adina Iftimi, Christina Yau

JAMA Netw Open· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IP6K2 predicts favorable clinical outcome of primary breast cancer.
Josefine Sandström, Alien Balian, Rebecca Lockowandt, Tommy Fornander, Bo Nordenskjöld

Mol Clin Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer.
Karoline Berger, Sara Rhost, Svanheiður Rafnsdóttir, Éamon Hughes, Ylva Magnusson

BMC Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.
Sanne Løkkegaard, Daniel Elias, Carla L Alves, Martin V Bennetzen, Anne-Vibeke Lænkholm

NPJ Breast Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.
Christine Lundgren, Pär-Ola Bendahl, Maria Ekholm, Mårten Fernö, Carina Forsare

Breast Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast-conserving surgery: a long-term follow-up of the SweBCG91-RT randomised trial.
Martin Sjöström, Cynthia Veenstra, Erik Holmberg, Per Karlsson, Fredrika Killander

Mol Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor-positive/progesterone receptor-negative breast cancer.
Helena Fohlin, Tove Bekkhus, Josefine Sandström, Tommy Fornander, Bo Nordenskjöld

Mol Clin Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAB6C is an independent prognostic factor of estrogen receptor-positive/progesterone receptor-negative breast cancer.
Helena Fohlin, Tove Bekkhus, Josefine Sandström, Tommy Fornander, Bo Nordenskjöld

Oncol Lett· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer.
Nancy Y Yu, Adina Iftimi, Christina Yau, Nicholas P Tobin, Laura van 't Veer

JAMA Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype.
Cynthia Veenstra, Elin Karlsson, Sanam Mirwani Mirwani, Bo Nordenskjöld, Tommy Fornander

J Cancer Res Clin Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer.
Elin Karlsson, Cynthia Veenstra, Jon Gårsjö, Bo Nordenskjöld, Tommy Fornander

J Cancer Res Clin Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumab.
Sander Ellegård, Cynthia Veenstra, Gizeh Pérez-Tenorio, Victor Fagerström, Jon Gårsjö

Oncol Lett· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer.
Carina Forsare, Martin Bak, Anna-Karin Falck, Dorthe Grabau, Fredrika Killander

BMC Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis